ArticleBMC public health2025
Explanatory spatial modeling of COVID-19 vaccine coverage in Thailand: policy implications for equitable distribution.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Spatiotemporal trends in tuberculosis incidence in Thailand, 2012-2023: a nationwide, province-level analysis.Infectious diseases of poverty · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe COVID-19 pandemic posed significant challenges globally, with vaccine distribution being a critical factor for recovery. Despite achieving vaccination targets, Thailand faced disparities in vaccine coverage across regions. This study aims to explore spatial clustering patterns and examine socioeconomic, demographic, and health service-related determinants of COVID-19 vaccine coverage across Thailand. The findings are intended to inform strategies for equitable vaccine distribution.
methodA cross-sectional ecological study was conducted using secondary data from all 76 provinces in Thailand. Spatial analysis techniques were employed to assess spatial autocorrelation using Moran's I and Local Indicators of Spatial Association (LISA). Additionally, spatial regression models were developed to explain vaccine coverage. Three models were tested and compared: Ordinary Least Squares (OLS), Spatial Lag Model (SLM), and Spatial Error Model (SEM). Model performance was evaluated based on R², Akaike Information Criterion (AIC), Bayesian Information Criterion (BIC), log-likelihood, and residual diagnostics.
resultMoran's I and LISA indicated significant positive spatial autocorrelation in vaccine coverage for both 2021 (0.427) and 2022 (0.467), with high-high clusters primarily concentrated in the Eastern region. The Spatial Error Model demonstrated the best performance and was most suitable for explaining the spatial variation in COVID-19 vaccine coverage. In 2021, vaccine coverage was associated with population density, nighttime light (NTL), public transport, income, health workers, COVID-19 cases and deaths (R² = 0.699). In 2022, key factors were the elderly population, nighttime light, internet access, and health workers (R² = 0.610).
conclusionWe conclude that in 2021, COVID-19 vaccine availability saw limited vaccine quantities distributed unevenly. Areas with substantial economic growth, high COVID-19 incidence rates, and a significant presence of health workers tended to have higher COVID-19 vaccine coverage. In 2022, vaccine availability improved with extensive distribution and community-level services targeting vulnerable groups, supported by online decision-making tools and a reservation system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.